Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Legrand

Showing results (61-70 of 80) with videos related to

Pageof 8
Sort By:
The American Journal of Cardiology|November 9, 2002
Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized TrialLaura Mauri, Raoul Bonan, Bonnie H Weiner, et al.
Journal of the American College of Cardiology|December 6, 2008
Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trialJoost Daemen, Karl Heinz Kuck, Carlos Macaya, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trialBimmer E Claessen, Marcel A Beijk, Victor Legrand, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.Sirolimus stent vs. coronary artery bypass surgery and bare metal stent: insights from ARTS-II and ARTS-ICarlos Macaya, Héctor M García-García, Antonio Colombo, et al.
International Journal of Cardiology|April 23, 2013
Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registryManel Sabaté, Salvatore Brugaletta, Alexandre Abizaid, et al.
JACC. Cardiovascular Interventions|January 11, 2012
The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registryAlexandre Abizaid, J Ribamar Costa, Adrian Banning, et al.
Journal of the American College of Cardiology|December 21, 2013
Reply: The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE)Jozef Bartunek, Atta Behfar, Dariouch Dolatabadi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 14, 2011
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registryFlorim Cuculi, Adrian P Banning, Alexander Abizaid, et al.
Journal of the American College of Cardiology|April 16, 2013
Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologicsJozef Bartunek, Atta Behfar, Dariouch Dolatabadi, et al.
Journal of the American College of Cardiology|February 2, 2002
A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) studyPatrick W Serruys, David P Foley, Martin Jan Suttorp, et al.
Pageof 8

Showing results (61-70 of 80) with videos related to

Sort By:
Pageof 8
The American Journal of Cardiology|November 9, 2002
Cutting balloon angioplasty for the prevention of restenosis: results of the Cutting Balloon Global Randomized TrialLaura Mauri, Raoul Bonan, Bonnie H Weiner, et al.
Journal of the American College of Cardiology|December 6, 2008
Multivessel coronary revascularization in patients with and without diabetes mellitus: 3-year follow-up of the ARTS-II (Arterial Revascularization Therapies Study-Part II) trialJoost Daemen, Karl Heinz Kuck, Carlos Macaya, et al.
Circulation. Cardiovascular Interventions|December 25, 2009
Two-year clinical, angiographic, and intravascular ultrasound follow-up of the XIENCE V everolimus-eluting stent in the treatment of patients with de novo native coronary artery lesions: the SPIRIT II trialBimmer E Claessen, Marcel A Beijk, Victor Legrand, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 17, 2009
One-year results of coronary revascularization in diabetic patients with multivessel coronary artery disease.Sirolimus stent vs. coronary artery bypass surgery and bare metal stent: insights from ARTS-II and ARTS-ICarlos Macaya, Héctor M García-García, Antonio Colombo, et al.
International Journal of Cardiology|April 23, 2013
Drug eluting stent implantation in patients requiring concomitant vitamin K antagonist therapy. One-year outcome of the worldwide e-SELECT registryManel Sabaté, Salvatore Brugaletta, Alexandre Abizaid, et al.
JACC. Cardiovascular Interventions|January 11, 2012
The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registryAlexandre Abizaid, J Ribamar Costa, Adrian Banning, et al.
Journal of the American College of Cardiology|December 21, 2013
Reply: The C-CURE Randomized Clinical Trial (Cardiopoietic stem Cell therapy in heart failURE)Jozef Bartunek, Atta Behfar, Dariouch Dolatabadi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|December 14, 2011
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registryFlorim Cuculi, Adrian P Banning, Alexander Abizaid, et al.
Journal of the American College of Cardiology|April 16, 2013
Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologicsJozef Bartunek, Atta Behfar, Dariouch Dolatabadi, et al.
Journal of the American College of Cardiology|February 2, 2002
A randomized comparison of the value of additional stenting after optimal balloon angioplasty for long coronary lesions: final results of the additional value of NIR stents for treatment of long coronary lesions (ADVANCE) studyPatrick W Serruys, David P Foley, Martin Jan Suttorp, et al.
Pageof 8